Increasing evidence shows that pathological samples from C9orf72-related ALS-FTD exhibit elevated levels of DNA damage markers, including γ-H2AX and phosphorylated ATM (pATM) (Walker et al., 2017; Farg et al., 2017). Here, C9orf72 is linked to frontotemporal dementia.